Clean Collect Blood Culture Diversion System Available to Intalere Members through New Agreement with Stone Medical Corporation
St. Louis (July 29, 2020) – Intalere, the healthcare industry leader in delivering solutions designed for improved financial, operational, and clinical health for our partners, announces a new agreement for the patented blood culture diversion system from Stone Medical Corporation.
Through this agreement Intalere members will receive negotiated pricing on Stone Medical’s Clean Collect® Blood Culture Diversion System and Quality Assurance support to hospitals. Clean Collect uses a patented diversion system to significantly reduce blood culture contamination rates and achieve long term control of the problem. This system has proven effective in clinical practice at hospitals and ERs dealing with difficult contamination issues.
This contract is currently effective through June 30, 2023.
About Stone Medical Corporation
The Stone Medical Corporation is a privately held company founded to bring exciting new technologies to the worldwide healthcare market and establish new standards of safety, quality, and efficacy. Our flagship product line Clean Collect proves our dedication to this mission by dramatically increasing the quality of blood cultures at hospitals. Our customers benefit from impressive cost reductions and improved patient outcomes. To learn more, visit www.stonemedcorp.com.
Intalere’s mission focuses on elevating the health of healthcare by designing solutions to improve our members’ financial, operational and clinical performance. We empower our customers and deliver measurable results through our highly personalized approach of creating strategies and programs focused on their goals. From managing their entire spend to strategic consulting around diagnosing particular areas of concern, our unique provider led model allows us to leverage nationally recognized best practices in supply chain and patient outcomes to drive efficiencies for our members. To learn more, visit www.intalere.com.